Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee
- PMID: 30350299
- PMCID: PMC6220006
- DOI: 10.1007/s12178-018-9524-x
Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee
Abstract
Purpose of review: The purpose of this review is to update the reader on the current applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This review will focus on PRP's effect on the osteoarthritic joint, how PRP compares to traditional treatments of KOA, and provide clinical feedback on the use of PRP in an orthopedic and sports medicine practice.
Recent findings: Recent research into the applications of PRP for KOA has further indicated both the efficacy and safety of PRP treatment. Although research has shown a tendency toward better efficacy at earlier stages of osteoarthritis (OA), evidence exists to indicate positive effects at all stages of OA. In summary, since KOA is an extremely prevalent condition that can be a challenge to treat, it is imperative that safe and effective nonoperative treatment methods be available to individuals that are suffering from this condition.
Keywords: Intra-articular; Knee; Osteoarthritis; PRP; Platelet-rich plasma.
Conflict of interest statement
Conflict of Interest
Dr. Smith is a consultant for Arthrex and receives research support from them.
Dr. Cook has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Figures


References
-
- Sibille Kimberly T., Chen Huaihou, Bartley Emily J., Riley Joseph, Glover Toni L., King Christopher D., Zhang Hang, Cruz-Almeida Yenisel, Goodin Burel R., Sotolongo Adriana, Petrov Megan E., Herbert Matthew, Bulls Hailey W., Edberg Jeffrey C., Staud Roland, Redden David, Bradley Laurence A., Fillingim Roger B. Accelerated aging in adults with knee osteoarthritis pain. PAIN Reports. 2017;2(3):e591. doi: 10.1097/PR9.0000000000000591. - DOI - PMC - PubMed
-
- Torio CM, Moore BJ. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204. 2016 May. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Available from: https://www.ncbi.nlm.nih.gov/books /NBK368492/. Accessed 15 July 2018. - PubMed
-
- Zhao L, Kaye AD, Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review. Pain Physician. 2018;21:229–241. - PubMed
-
- Torstensen TA, Grooten WJA, Østerås H, Heijne A, Harms-Ringdahl K, Äng BO. How does exercise dose affect patients with long-term osteoarthritis of the knee? A study protocol of a randomised controlled trial in Sweden and Norway: the SWENOR Study. BMJ Open. 2018;8:e018471. doi: 10.1136/bmjopen-2017-018471. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical
Research Materials